Your Comments On...

Cost Benefits of New Schizophrenia Drugs Doubted

Treating schizophrenia with an older, cheaper drug, rather than with heavily promoted newer medications, reduces the cost by as much as 30 percent with no apparent difference in safety and effectiveness, according to the first study to examine the economic implications of antipsychotic drug...
 - 

By Shankar Vedantam

 
Comments
© 2006 The Washington Post Company